SmithKline Beecham's chief scientific officer, George Poste, speaks of pharmacogenomics as the savior of the industry.
FORBES: Tailor-made drugs
Among the first to recognize this potential was George Poste, former chief scientist for SmithKline Beecham.
FORBES: Divining Disease
In 1996 SmithKline Beecham vowed to discover two new antibiotic classes by 2003.
FORBES: Germ Warfare
应用推荐
模块上移
模块下移
不移动